January 17, 2017 — Medtronic plc announced the CE (Conformité Européenne) mark and European launch of the CoreValve ...
Diagnostic and Interventional Cardiology DAIC
Diagnostic and Interventional Cardiology (DAIC) is a magazine that reaches more than 25,000 healthcare professionals in cardiology, interventional cardiology and cath labs across the United States. These influential buying team members rely on DAIC's award-winning editorial content and comparison charts as a unique research tool for specifying, recommending and approving technology/device purchases.
January 17, 2017 — Investigators at the University of Utah have identified distinct differences in the hearts of ...
January 17, 2017 — The new SunTech Oscar 2 24-hour ambulatory blood pressure monitoring system (ABPM) is now available ...
January 16, 2017 — Frost & Sullivan has released a new report, “Vision 2025 – Future of Healthcare,” part of the company ...
January 16, 2017 – In 2015, researchers and physicians at the Minneapolis Heart Institute Foundation (MHIF) were the ...
January 13, 2017 — BioTrace Medical Inc. announced in December the first commercial use of the company’s Tempo Temporary ...
Detailed imaging is needed to support complex interventions for the assessment and procedure guidance. See how the GE ...
January 12, 2017 — International healthcare-focused merger and acquisition (M+A) advisory firm Vertess recently shared ...
January 11, 2017 — According to a recent study by the Harvey L. Neiman Health Policy Institute, the last two decades ...
January 11, 2017 — Lombard Medical Inc. recently announced approval from the Japanese Ministry of Health, Labour and ...
January 10, 2017 — BioVentrix Inc. announced in December the first closed-chest Revivent TC TransCatheter Ventricular ...
January 10, 2017 — Ischemic heart failure from previous heart attacks and coronary artery disease is the leading cause ...
Effective July 1, 2017 for Medicare heart attack patients, the the Centers for Medicare and Medicaid Services (CMS) will ...
January 9, 2017 — BioCardia Inc. announced in December the issuance of United States Patent No. 9,517,199 relating to a ...
January 6, 2017 — SentreHeart Inc. announced that it has completed the Stage I enrollment milestone in the aMAZE Trial ...